12th Edition of International Conference on
Neurology and Neurological Disorders
June 22-24, 2026 | Barcelona, Spain
Translational Neurology
The dynamic field of translational neurology focuses on converting scientific research into therapeutic strategies for complex neurological disorders. It explores the pathways of neurodegeneration, aiming to identify biomarkers and novel drug targets for early intervention. Through interdisciplinary collaboration, Translational Neurology leverages advancements in molecular biology, bioinformatics, and neuroengineering to design cutting-edge treatments. Techniques such as brain-machine interfaces and neurostimulation are emerging as transformative tools in restoring function for patients with neurological impairments. This approach emphasizes precision medicine, ensuring that therapies are tailored to the genetic and molecular profiles of individuals, ultimately driving progress in the treatment of challenging neurological conditions.
Ken Ware
NeuroPhysics Therapy Institute, Australia
Robert B Slocum
University of Kentucky HealthCare, United States
Yong Xiao Wang
Albany Medical College, United States
Milton Cesar Rodrigues Medeiros
Hospital Santa Casa de Arapongas, Brazil
Zhenhuan Liu
Guangzhou University of Chinese Medicine, China
Jaqueline Tuppen
COGS Club, United Kingdom
Luiz Moutinho
University of Suffolk, United KingdomSubmit your abstract Today
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom